期刊文献+

心肌细胞肥大病理生理研究进展 被引量:1

下载PDF
导出
摘要 综述近年来心肌细胞肥大发生的机制,包括心肌细胞肥大的刺激因素及相关信号传导途径等。
作者 张军
出处 《中国社区医师(医学专业)》 2011年第15期9-9,共1页
  • 相关文献

参考文献3

二级参考文献17

  • 1Fleisch M, Sutsch G, Yan X W. Systemic pulmonary and renal hemodynamic effects of endothelin ET(A/B) receptor blockade in patients with maintained left ventricular function. J Cardiovasc Pharmacol, 2000, 36:302-309.
  • 2Haynes W G, Webb D G. Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens, 1998, 16:1081-1098.
  • 3Ohnishi M, Wada A, Tsutamoto T, et al. Significant roles of endothelin A and B receptors in renal function in congestive heart failure, J Cardiovasc Pharmacol, 2000, 36(5 Suppl 1):140-143.
  • 4Lepailleur-enouf D, Egidy G, Philippe M, et al. Pulmony endothelin system in experimental congestive heart failure. Cardiovas Res, 2001, 49:330-339.
  • 5Ry S D, Andreassi M G, Clerico A, et al. Endothelin1, endothelin receptors and cardiac natriuretic peptides in failing human heart. Life Science, 2001, 4: 221-230.
  • 6Adams JW, Migita DS, Yu MK, et al.Prostaglandin F2 alpha stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes. J Biol Chem, 1996;271(2):1179 - 1186.
  • 7Harary I, Farley B. In vitro studies of single isolated beating heart cell.Science, 1960;131:1674-1675.
  • 8Karmazyn M. Synthesis and relevance of cardiac eicosanoids with particular emphasis on ischemia and reperfusion. Can J Physiol pharmacol, 1989;67(8):912-921.
  • 9Adams JW, Sah VP, Henderson SA, Brown HJ. Tyrosine kinase and c-jun NH2-terminal kinase mediate hypertrophic response to prostaglandin F2αin cultured neonatal rat ventricular myocytes. Circ Res, 1998;83(2):167-178.
  • 10Ruwhof C, van der Laarse A. Mechanical stress-induced cardiac hypertrophy:mechanisms and signal transduction pathways.Cardiovasc Res,2000;47(1):23 - 37.

共引文献6

同被引文献30

  • 1王彦珍,孙胜,蔡莉蓉,刘凤英,刘秀华.大鼠腹主动脉狭窄高血压心肌肥厚模型的优化[J].军医进修学院学报,2004,25(3):231-232. 被引量:19
  • 2Bernardo BC, Weeks KL, Pretorius L, et al. Molecular distinction between physiological and pathological cardiac hypertrophy, experimental findings and therapeutic strate- gies[J]. Pharmacology Therapeutics,2010,128( 1 ). 191.
  • 3吴平生.肥厚型心肌病流行病学及分子遗传学特点[C].北京:第5届国际心血管热点论坛:心脏交叉论坛,2013.
  • 4Pluim BM, Zwinderman AH, Vander LA, et al. The ath- lete' s heart: a recta-analysis of cardiac structure and func- tion[J]. Circulation, 2000,101 (3) : 336.
  • 5Kodama H, Fukuda K, Pan J, et al. Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat eardiomyocytes[J]. Cire Res, 1997,81(5) :656.
  • 6Molkentin JD, Dora IG. Cytoplasmic signaling pathways that regulate cardiac hypertrophy[J]. Annu Rev Physiol, 2001,63 : 391.
  • 7Backs J, Olson EN. Control of cardiac growth by histone acetylation deacetylation[J]. Circ Res, 2006,98 ( 1 ) : 15.
  • 8Rockman HA, Ross RS, Harris AN, et al. Segregation of atrial-specific and inducible expression of an atrial natri- uretic factor transgene in an in vivo murine model of car- diac hypertrophy[J]. Proc Natl Acad Sei U S A, 1991,88 (18) :8 277.
  • 9Van Rooij E, Olson EN. MicroRNAs: powerful new regu- lators of heart disease and provocative therapeutic targets [J]. J Clin Invest, 2007,117(9) : 2 369.
  • 10Freund C, Schmidt-Ullrich R, Baurand A, et al. Require- ment of nuclear factor-kappaB in angiotensin Ⅱ -and iso- proterenol-induced cardiac hypertrophy in vivo[J]. Circu- lation,2005,111(18) :2 319.

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部